<!DOCTYPE html>
    <html lang="en">
    
    <head>
        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <script async src="https://www.googletagmanager.com/gtag/js?id=G-PQPWWZGD1B"></script>
        <script>
        window.dataLayer = window.dataLayer || [];
        function gtag(){dataLayer.push(arguments);}
        gtag('js', new Date());

        gtag('config', 'G-PQPWWZGD1B');
        </script>
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-7833742603914548"
     crossorigin="anonymous"></script>
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.0/dist/katex.min.css" integrity="sha384-Xi8rHCmBmhbuyyhbI88391ZKP2dmfnOl4rT9ZfRI7mLTdk1wblIUnrIq35nqwEvC" crossorigin="anonymous">
        <link rel="stylesheet" href="../assets/css/min/@ui.css">
        <link rel="shortcut icon" href="../assets/images/favicons/favicon.ico">
        <link rel="apple-touch-icon-precomposed" href="../assets/images/favicons/apple-touch-icon-152x152-precomposed.png">
        <link rel="apple-touch-icon" sizes="180x180" href="../assets/images/favicons/apple-touch-icon.png">
        <link rel="icon" type="image/png" sizes="32x32" href="../assets/images/favicons/favicon-32x32.png">
        <link rel="icon" type="image/png" sizes="16x16" href="../assets/images/favicons/favicon-16x16.png">
        <link rel="manifest" href="../assets/images/favicons/site.webmanifest">
        <link rel="mask-icon" href="../assets/images/favicons/safari-pinned-tab.svg" color="#10106d">
        <meta name="msapplication-TileColor" content="#10106d">
        <meta name="msapplication-config" content="/assets/images/favicons/browserconfig.xml">
        <meta name="theme-color" content="#10106d">
        <link rel="canonical" href="https://vlavar.com/engineeringdb/biotechnics-engineering-has-developed-two-mutually-exclusive-plans-for-investing-in-new-capital-equipment-with-the-expectation-of-increased-revenue-from-its-medical-diagnostic-services-to-cancer-patie" />
        <meta property="og:locale" content="en_US" />
        <meta property="og:type" content="article" />
        <meta property="og:site_name" content="Vlavar" />
        <meta property="article:publisher" content="admin@vlavar" />
       <title>Biotechnics Engineering has developed two mutually exclusive plans for investing in new capital equipment with the expectation of increased revenue from its medical diagnostic services to cancer patients. The estimates are summarized below. (a) Use classical straight line depreciation, an after-tax [solved] | Vlavar Engineering</title>
<meta property="og:title" content="Biotechnics Engineering has developed two mutually exclusive plans for investing in new capital equipment with the expectation of increased revenue from its medical diagnostic services to cancer patients. The estimates are summarized below. (a) Use classical straight line depreciation, an after-tax[solved!] | Vlavar Engineering" />
<meta name="description" content="(a) Refer to the spreadsheet and function cells (row 22) in Figure 17–9. EVA evaluation: All the necessary information for EVA estimation is determined in"/>
<meta property="og:description" content="(a) Refer to the spreadsheet and function cells (row 22) in Figure 17–9. EVA evaluation: All the necessary information for EVA estimation is determined in" />


<meta name="twitter:description" content="(a) Refer to the spreadsheet and function cells (row 22) in Figure 17–9. EVA evaluation: All the necessary information for EVA estimation is determined in" />
<meta name="twitter:title" content="Biotechnics Engineering has developed two mutually exclusive plans for investing in new capital equipment with the expectation of increased revenue from its medical diagnostic services to cancer patients. The estimates are summarized below. (a) Use classical straight line depreciation, an after-tax[solved!] | Vlavar Engineering" />

<meta property="article:published_time" content="2022-07-01T06:49:39+04:00" />
        <meta property="og:url" content="https://vlavar.com/engineeringdb/biotechnics-engineering-has-developed-two-mutually-exclusive-plans-for-investing-in-new-capital-equipment-with-the-expectation-of-increased-revenue-from-its-medical-diagnostic-services-to-cancer-patie" />
        <meta property="article:author" content="admin@vlavar" />
        <meta name="twitter:card" content="summary_large_image" />
        <meta name="twitter:site" content="admin@vlavar" />
        <meta name="twitter:creator" content="admin@vlavar" />
     
    </head>
    
    <body>
        <nav id="desktop" class="desktop">
            <div id="desktop-container" class="container">
                <h1 id="logo"><a href="../index.html">Vlavar</a></h1>
                <div id="desktop-menu" class="menu">
                    <a href="../index.html">Home</a>
                    <a id="search">Search</a>
                    <a href="../tour/1.html">Tour</a>
                    <a href="../contact-us.html">Contact Us</a>
                </div>
                <button id="burger-button" class="hamburger">
                    <span></span>
                    <span></span>
                    <span></span>
                </button>
    
            </div>
        </nav>
        <nav id="mobile-navbar" class="mobile-nav">
            <div class="one text-fade"><a class="nav-link" href="../index.html">Home</a></div>
            <div class="two text-fade"><a class="nav-link" id="search-mobile">Search</a></div>
            <div class="three text-fade"><a class="nav-link" href="../tour/1.html">Tour</a></div>
            <div class="four text-fade"><a class="nav-link" href="../contact-us.html">COntact Us</a></div>
        </nav>
    
        <div id="container" class="container-items tour">
            <div id="searchbox" class="searchbox">
                <div class="search">
                    <div class="icon"></div>
                    <form class="form">
                        <div class="input">
                        <input type="text" id="x" placeholder="Find solutions to engineering problems " autocomplete="off" >

                        </div>
                    </form>
                </div>
            </div>
            <div class="items question-block"> <span class="question">Guest Question. </span>
            <p class="blog">Biotechnics Engineering has developed two mutually exclusive plans for investing in new capital equipment with the expectation of increased revenue from its medical diagnostic services to cancer patients. The estimates are summarized below. (a) Use classical straight line depreciation, an after-tax MARR of 12%, and an effective tax rate of 40% to perform two annual worth after-tax analyses: EVA and CFAT. (b) Explain the fundamental difference between the results of the two analyses.</p>  <div class="table-overflow"><table > <table style="border-collapse: collapse;width: 651px;height: 314px" border="0" width="216" cellspacing="0" cellpadding="0"> <tbody> <tr style="height: 14.25pt"> <td style="height: 14.25pt;width: 54pt" width="72" height="19"></td> <td style="width: 54pt;text-align: center" width="72">Plan A</td> <td style="width: 54pt;text-align: center" width="72">Plan B</td> </tr> <tr style="height: 14.25pt"> <td style="height: 14.25pt" height="19">Initial investment, $</td> <td style="text-align: center">-500,00</td> <td style="text-align: center">-1,200,000</td> </tr> <tr style="height: 14.25pt"> <td style="height: 14.25pt" height="19">Gross income − expenses, $</td> <td style="text-align: center">170,000 per year</td> <td style="text-align: center">600,000 in year 1, decreasing by 100,000<br /> per year thereafter</td> </tr> <tr style="height: 14.25pt"> <td style="height: 14.25pt" height="19">Estimated life, years</td> <td style="text-align: center">4</td> <td style="text-align: center">4</td> </tr> <tr style="height: 14.25pt"> <td style="height: 14.25pt" height="19">Salvage value</td> <td style="text-align: center">None</td> <td style="text-align: center">None</td> </tr> </tbody> </table></div> </table>      
    <!-- end -->
            </div>
    
            <div class="items blog-solution">
                <div class="admin"><span>Admin</span> <svg class="verified-badge" xmlns="http://www.w3.org/2000/svg"
                        version="1.1" viewBox="0,0,24,24">
                        <path
                            d="M22.5 12.5c0-1.58-.875-2.95-2.148-3.6.154-.435.238-.905.238-1.4 0-2.21-1.71-3.998-3.818-3.998-.47 0-.92.084-1.336.25C14.818 2.415 13.51 1.5 12 1.5s-2.816.917-3.437 2.25c-.415-.165-.866-.25-1.336-.25-2.11 0-3.818 1.79-3.818 4 0 .494.083.964.237 1.4-1.272.65-2.147 2.018-2.147 3.6 0 1.495.782 2.798 1.942 3.486-.02.17-.032.34-.032.514 0 2.21 1.708 4 3.818 4 .47 0 .92-.086 1.335-.25.62 1.334 1.926 2.25 3.437 2.25 1.512 0 2.818-.916 3.437-2.25.415.163.865.248 1.336.248 2.11 0 3.818-1.79 3.818-4 0-.174-.012-.344-.033-.513 1.158-.687 1.943-1.99 1.943-3.484zm-6.616-3.334l-4.334 6.5c-.145.217-.382.334-.625.334-.143 0-.288-.04-.416-.126l-.115-.094-2.415-2.415c-.293-.293-.293-.768 0-1.06s.768-.294 1.06 0l1.77 1.767 3.825-5.74c.23-.345.696-.436 1.04-.207.346.23.44.696.21 1.04z"
                            fill="#1da1f2" />
                    </svg> </div>
    
                <div class="solution">Solution</div>
    
            </div>
    
            <div class="items answer-block">
                <p class="blog">
(a) Refer to the spreadsheet and function cells (row 22) in Figure 17–9.<br /> EVA evaluation: All the necessary information for EVA estimation is determined in columns B through G. The net operating profit after taxes (NOPAT) in column H is calculated by Equation [17.4] [NOPAT== TI(1 − T)], TI − taxes. The book values (column E) are used to determine the cost of invested capital in column I, using the second term in Equation [17.23][EVA<br /> =<span class="tex-text">\( TI(1 − T_{e}) − (i)(BV_{t}−1)\)</span>], that is, i(<span class="tex-text">\(BV_{t}\)</span>−1), where i is the 12% after-tax MARR. This represents the amount of interest at 12% per year, after taxes, for the currently invested capital as reflected by the book value at the beginning of the year. The EVA estimate is the sum of columns H and I for years 1 through 4. Notice there is no EVA estimate for year 0, since NOPAT and the cost of invested capital are estimated for years 1 through n. Finally, the larger AW of the EVA value is selected, which indicates that plan B is better and that plan A does not make the 12% return.<br /> CFAT evaluation: As shown in function row 22 (plan B for year 3), CFAT estimates (column K) are calculated as (GI − OE) − P − taxes. The AW of CFAT again concludes that plan B is better and that plan A does not return the after-tax MARR of 12% (K10).<br /> (b) What is the fundamental difference between the EVA and CFAT series in columns J and K?<br /> They are clearly equivalent from the time value of money perspective since the AW values are numerically the same. To answer the question, consider plan A, which has a constant CFAT estimate of $152,000 per year. To obtain the AW of EVA estimate of $−12,617 for years 1 through 4, the initial investment of $500,000 is distributed over the 4-year life using the A∕P factor at 12%. That is, an equivalent amount of $500,000(A∕P,12%,4) = $164,617 is “charged” against the cash inflows in each of years 1 through 4. In effect, the yearly CFAT is reduced by this charge.</p>
 <p style="text-align: center">CFAT − (initial investment)(A∕P,12%,4) = 152,000 − 500,000(A∕P,12%,4)=152,000 − 164,617 = $−12,617= AW of EVA</p>
 <p class="blog">
This is the AW value for both series, demonstrating that the two methods are economically equivalent. However, the EVA method indicates an alternative’s yearly estimated contribution to the value of the corporation, whereas the CFAT method estimates the actual cash flows to the corporation. This is why the EVA method is often more popular than the cash flow method with corporate executives.</p>
 <p class="blog">
<strong>Comment</strong><br /> The calculation P(A∕P,i,n) = $500,000(A∕P,12%,4) is exactly the same as the capital recovery in Equation [6.3][CR = −P(A∕P,i,n) + S(A∕F,i,n)], assuming an estimated salvage value of zero. Thus, the cost of invested capital for EVA is the same as the capital recovery discussed in Chapter 6. This further demonstrates why the AW method is economically equivalent to the EVA evaluati</p>
 
    
          <!-- end -->
            </div>
        </div>
    
    
        <footer class="footer-bg footer-slct">
            <div class="footer-top">
                <a href="../tos.html">terms</a>
                <a href="../privacy.html">privacy</a>
                <a href="../contact-us.html">contact us</a>
            </div>
            <div class="footer-bottom">
                &copy; 2022 Vlavar Inc. All Rights Reserved.
            </div>
        </footer>    
        <script src="https://cdn.jsdelivr.net/npm/katex@0.16.0/dist/katex.min.js" integrity="sha384-X/XCfMm41VSsqRNQgDerQczD69XqmjOOOwYQvr/uuC+j4OPoNhVgjdGFwhvN02Ja" crossorigin="anonymous"></script>
        <script src="https://cdn.jsdelivr.net/npm/katex@0.16.0/dist/contrib/auto-render.min.js" integrity="sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR" crossorigin="anonymous"></script>
        <script src="../assets/js/min/client-ui.js"></script>
    </body>
    
    </html>